eltrombopag
(DJMJHIKGMVJYCW-UHFFFAOYSA-N)
Structure
- SMILES
- OC(=O)c1cccc(c1)c1cccc(c1O)N=Nc1c(C)[nH]n(c1=O)c1ccc(c(c1)C)C.NCCO.NCCO
- Molecular Formula:
- C29H36N6O6
- Molecular Weight:
- 564.633
- Log P:
- 4.8524
- Hydrogen Bond Acceptor:
- 11
- Hydrogen Bond Donor:
- 7
- TPSA:
- 212.54
- CAS Number(s):
- 496775-62-3
Synonym(s)
1.
eltrombopag
2.
Promacta
3.
Revolade
4.
SB-497 115
External Link(s)
| MeSH | C520809 |
| PubChem Compound | 135449331 |
| CHEMBL | CHEMBL3989691 |
| KEGG | dr:D03978 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 58 Canada Vigilance: 56 | Canada Vigilance US FAERS | |
| 2 | Headache | FAERS: 39 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 3 | Malaise | FAERS: 39 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 4 | Product use in unapproved indication | FAERS: 37 | US FAERS | |
| 5 | Pulmonary Embolism | FAERS: 35 | US FAERS | |
| 6 | Thrombocytopenia | FAERS: 35 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Pneumonia | FAERS: 28 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Thrombosis | FAERS: 28 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Epistaxis | FAERS: 23 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 10 | Disease Progression | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Petechiae | FAERS: 22 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 12 | Dizziness | FAERS: 21 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 13 | Myelofibrosis | FAERS: 21 | US FAERS | |
| 14 | Myocardial Infarction | FAERS: 21 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 15 | Nausea | FAERS: 21 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 16 | Sepsis | FAERS: 21 | US FAERS | |
| 17 | Pain | FAERS: 20 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 18 | Cerebrovascular accident | FAERS: 19 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 19 | Platelet count abnormal | FAERS: 19 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 20 | Vomiting | FAERS: 19 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 21 | Infection | FAERS: 18 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 22 | Fatigue | FAERS: 17 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 23 | Abdominal Pain | FAERS: 16 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 24 | Chest Pain | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 25 | Blindness | FAERS: 14 | US FAERS | |
| 26 | Influenza | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Product use issue | FAERS: 14 | US FAERS | |
| 28 | Asthenia | FAERS: 13 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 29 | General physical health deterioration | FAERS: 13 | US FAERS | |
| 30 | White blood cell count decreased | FAERS: 13 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 31 | Arthralgia | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 32 | Deep Vein Thrombosis | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 33 | Maternal exposure during pregnancy | FAERS: 12 | US FAERS | |
| 34 | Myalgia | FAERS: 12 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 35 | Pruritus | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 36 | Urinary tract infection | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 37 | Immune thrombocytopenic purpura | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Oropharyngeal pain | FAERS: 11 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 39 | Portal Vein Thrombosis | FAERS: 11 | US FAERS | |
| 40 | Thrombocytosis | FAERS: 11 | US FAERS | |
| 41 | jaundice | FAERS: 11 | US FAERS | |
| 42 | Alopecia | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 43 | Cerebral Infarction | FAERS: 10 | US FAERS | |
| 44 | Somnolence | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Weight decreased | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 46 | Wrong technique in product usage process | FAERS: 10 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 47 | Disease recurrence | FAERS: 9 | US FAERS | |
| 48 | Incorrect dose administered | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | MYELODYSPLASTIC SYNDROME | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Ascites | FAERS: 8 | US FAERS | |
| 51 | Back Pain | FAERS: 8 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 52 | Blood creatinine increased | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 53 | Embolism | FAERS: 8 | US FAERS | |
| 54 | Feeling abnormal | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 55 | Pancreatitis | FAERS: 8 | US FAERS | |
| 56 | Visual Impairment | FAERS: 8 | US FAERS | |
| 57 | Bone pain | FAERS: 7 | US FAERS | |
| 58 | Chills | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 59 | Inappropriate schedule of product administration | FAERS: 7 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 60 | Pulmonary Infarction | FAERS: 7 | US FAERS | |
| 61 | Transaminases increased | FAERS: 7 | US FAERS | |
| 62 | Acute myocardial infarction | FAERS: 6 | US FAERS | |
| 63 | Blood lactate dehydrogenase increased | FAERS: 6 | US FAERS | |
| 64 | Cardiac Arrest | FAERS: 6 | US FAERS | |
| 65 | Decreased immune responsiveness | FAERS: 6 | US FAERS | |
| 66 | Diabetes Mellitus | FAERS: 6 | US FAERS | |
| 67 | Hypersensitivity | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Inappropriate schedule of drug administration | FAERS: 6 | US FAERS | |
| 69 | Swelling | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 70 | Tachycardia | FAERS: 6 | US FAERS | |
| 71 | Therapy non-responder | FAERS: 6 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 72 | Arterial thrombosis | FAERS: 5 | US FAERS | |
| 73 | Atrial Fibrillation | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 74 | Blast cell count increased | FAERS: 5 | US FAERS | |
| 75 | Blood glucose increased | FAERS: 5 | US FAERS | |
| 76 | Constipation | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 77 | Discomfort | FAERS: 5 | US FAERS | |
| 78 | Hepatomegaly | FAERS: 5 | US FAERS | |
| 79 | Hepatotoxicity | FAERS: 5 | US FAERS | |
| 80 | Inflammation | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 81 | Lymphadenopathy | FAERS: 5 | US FAERS | |
| 82 | Lymphoma | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 83 | Monocyte count increased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 84 | Musculoskeletal stiffness | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 85 | Nasopharyngitis | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 86 | Neutropenia | FAERS: 5 | US FAERS | |
| 87 | Pancytopenia | FAERS: 5 | US FAERS | |
| 88 | Phlebitis | FAERS: 5 | US FAERS | |
| 89 | Psychiatric symptom | FAERS: 5 | US FAERS | |
| 90 | Alanine Aminotransferase Increased | FAERS: 4 | US FAERS | |
| 91 | Anxiety | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 92 | Aphasia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 93 | Arthritis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 94 | Aspartate Aminotransferase Increased | FAERS: 4 | US FAERS | |
| 95 | Bone marrow reticulin fibrosis | FAERS: 4 | US FAERS | |
| 96 | Cerebral Thrombosis | FAERS: 4 | US FAERS | |
| 97 | Concomitant disease aggravated | FAERS: 4 | US FAERS | |
| 98 | Dyspepsia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 99 | Hypotension | FAERS: 4 | US FAERS | |
| 100 | Memory impairment | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 101 | Menorrhagia | FAERS: 4 | US FAERS | |
| 102 | Monoplegia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 103 | Musculoskeletal Pain | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | Nephrolithiasis | FAERS: 4 | US FAERS | |
| 105 | Overdose | FAERS: 4 | US FAERS | |
| 106 | Pallor | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 107 | Peripheral swelling | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 108 | Prescribed overdose | FAERS: 4 | US FAERS | |
| 109 | Pulmonary thrombosis | FAERS: 4 | US FAERS | |
| 110 | Splenomegaly | FAERS: 4 | US FAERS | |
| 111 | Syncope | FAERS: 4 | US FAERS | |
| 112 | White blood cell count abnormal | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 113 | Acute kidney injury | FAERS: 3 | US FAERS | |
| 114 | Amnesia | FAERS: 3 | US FAERS | |
| 115 | Aspiration bone marrow abnormal | FAERS: 3 | US FAERS | |
| 116 | Biopsy bone marrow abnormal | FAERS: 3 | US FAERS | |
| 117 | Blood glucose abnormal | FAERS: 3 | US FAERS | |
| 118 | Cataract | FAERS: 3 | US FAERS | |
| 119 | Cellulitis | FAERS: 3 | US FAERS | |
| 120 | Chest discomfort | FAERS: 3 | US FAERS | |
| 121 | Deafness | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Depressed mood | FAERS: 3 | US FAERS | |
| 123 | Eosinophilia | FAERS: 3 | US FAERS | |
| 124 | Flushing | FAERS: 3 | US FAERS | |
| 125 | Gamma-Glutamyltransferase Increased | FAERS: 3 | US FAERS | |
| 126 | Gastroenteritis | FAERS: 3 | US FAERS | |
| 127 | Glaucoma | FAERS: 3 | US FAERS | |
| 128 | Hepatitis C | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 129 | Leukocytosis | FAERS: 3 | US FAERS | |
| 130 | Malignant neoplasm progression | FAERS: 3 | US FAERS | |
| 131 | Neck Pain | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 132 | Neutrophil count decreased | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 133 | PCO2 decreased | FAERS: 3 | US FAERS | |
| 134 | Pancreatic carcinoma | FAERS: 3 | US FAERS | |
| 135 | Pelvic venous thrombosis | FAERS: 3 | US FAERS | |
| 136 | Pre-Eclampsia | FAERS: 3 | US FAERS | |
| 137 | Respiratory arrest | FAERS: 3 | US FAERS | |
| 138 | Septic Shock | FAERS: 3 | US FAERS | |
| 139 | Thrombocytopenic purpura | FAERS: 3 | US FAERS | |
| 140 | Urticaria | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 141 | Venous Thrombosis | FAERS: 3 | US FAERS | |
| 142 | Wound Infection | FAERS: 3 | US FAERS | |
| 143 | Abdominal Infection | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 144 | Abdominal discomfort | FAERS: 2 | US FAERS | |
| 145 | Agitation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 146 | Agranulocytosis | FAERS: 2 | US FAERS | |
| 147 | Angina Pectoris | FAERS: 2 | US FAERS | |
| 148 | Ankle Fracture | FAERS: 2 | US FAERS | |
| 149 | Antiphospholipid Syndrome | FAERS: 2 | US FAERS | |
| 150 | Apparent death | FAERS: 2 | US FAERS | |
| 151 | Asthma | FAERS: 2 | US FAERS | |
| 152 | Blood alkaline phosphatase increased | FAERS: 2 | US FAERS | |
| 153 | Blood iron decreased | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 154 | Blood sodium decreased | FAERS: 2 | US FAERS | |
| 155 | Blood urine present | FAERS: 2 | US FAERS | |
| 156 | Burning sensation | FAERS: 2 | US FAERS | |
| 157 | Chronic cheek biting | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 158 | Cystitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 159 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 160 | Dermatitis | FAERS: 2 | US FAERS | |
| 161 | Device related infection | FAERS: 2 | US FAERS | |
| 162 | Diabetes mellitus inadequate control | FAERS: 2 | US FAERS | |
| 163 | Disease complication | FAERS: 2 | US FAERS | |
| 164 | Disorientation | FAERS: 2 | US FAERS | |
| 165 | Embolic stroke | FAERS: 2 | US FAERS | |
| 166 | Enterocolitis | FAERS: 2 | US FAERS | |
| 167 | Epilepsy | FAERS: 2 | US FAERS | |
| 168 | Erythema | FAERS: 2 | US FAERS | |
| 169 | Extra dose administered | FAERS: 2 | US FAERS | |
| 170 | Fibrosis | FAERS: 2 | US FAERS | |
| 171 | Flatulence | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 172 | Full blood count decreased | FAERS: 2 | US FAERS | |
| 173 | Gastric ulcer | FAERS: 2 | US FAERS | |
| 174 | Gastritis | FAERS: 2 | US FAERS | |
| 175 | Glomerulonephritis | FAERS: 2 | US FAERS | |
| 176 | Hepatic Infection | FAERS: 2 | US FAERS | |
| 177 | Hepatic vein occlusion | FAERS: 2 | US FAERS | |
| 178 | Hepatitis | FAERS: 2 | US FAERS | |
| 179 | Hypokinesia | FAERS: 2 | US FAERS | |
| 180 | Ileus | FAERS: 2 | US FAERS | |
| 181 | Iron deficiency | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 182 | Joint swelling | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 183 | Leukopenia | FAERS: 2 | US FAERS | |
| 184 | Liver Abscess | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 185 | Lower respiratory tract infection | FAERS: 2 | US FAERS | |
| 186 | Lymphocyte count abnormal | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 187 | Megakaryocytes increased | FAERS: 2 | US FAERS | |
| 188 | Metastasis | FAERS: 2 | US FAERS | |
| 189 | Mouth swelling | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 190 | Nephrotic Syndrome | FAERS: 2 | US FAERS | |
| 191 | Nervousness | FAERS: 2 | US FAERS | |
| 192 | Neurological infection | FAERS: 2 | US FAERS | |
| 193 | Neutrophil count abnormal | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 194 | Night sweats | FAERS: 2 | US FAERS | |
| 195 | Pharyngitis | FAERS: 2 | US FAERS | |
| 196 | Product prescribing error | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 197 | Pulmonary Fibrosis | FAERS: 2 | US FAERS | |
| 198 | Pulmonary Hypertension | FAERS: 2 | US FAERS | |
| 199 | Respiratory Failure | FAERS: 2 | US FAERS | |
| 200 | Rhabdomyolysis | FAERS: 2 | US FAERS | |
| 201 | Rhinitis | FAERS: 2 | US FAERS | |
| 202 | Skin reaction | FAERS: 2 | US FAERS | |
| 203 | Stevens-Johnson Syndrome | FAERS: 2 | US FAERS | |
| 204 | Stress | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 205 | Sudden death | FAERS: 2 | US FAERS | |
| 206 | Terminal state | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 207 | Therapeutic response unexpected | FAERS: 2 | US FAERS | |
| 208 | Tongue biting | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 209 | Toothache | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 210 | Toxoplasmosis | FAERS: 2 | US FAERS | |
| 211 | Tremor | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 212 | Tuberculosis | FAERS: 2 | US FAERS | |
| 213 | Ventricular Fibrillation | FAERS: 2 | US FAERS | |
| 214 | treatment failure | FAERS: 2 | US FAERS | |
| 215 | Abasia | FAERS: 1 | US FAERS | |
| 216 | Acne | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 217 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 218 | Adenocarcinoma | FAERS: 1 | US FAERS | |
| 219 | Adverse event | FAERS: 1 | US FAERS | |
| 220 | Alcohol poisoning | FAERS: 1 | US FAERS | |
| 221 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 222 | Amylase increased | FAERS: 1 | US FAERS | |
| 223 | Anger | FAERS: 1 | US FAERS | |
| 224 | Angiogram abnormal | FAERS: 1 | US FAERS | |
| 225 | Aortic Rupture | FAERS: 1 | US FAERS | |
| 226 | Aortic occlusion | FAERS: 1 | US FAERS | |
| 227 | Aortitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 228 | Appendicitis | FAERS: 1 | US FAERS | |
| 229 | Arteriosclerosis | FAERS: 1 | US FAERS | |
| 230 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 231 | Autoimmune Pancreatitis | FAERS: 1 | US FAERS | |
| 232 | Autoimmune hepatitis | FAERS: 1 | US FAERS | |
| 233 | Autonomic nervous system imbalance | FAERS: 1 | US FAERS | |
| 234 | Basilar artery thrombosis | FAERS: 1 | US FAERS | |
| 235 | Beta 2 microglobulin urine increased | FAERS: 1 | US FAERS | |
| 236 | Beta-N-acetyl-D-glucosaminidase increased | FAERS: 1 | US FAERS | |
| 237 | Bilirubin conjugated increased | FAERS: 1 | US FAERS | |
| 238 | Blood bilirubin unconjugated increased | FAERS: 1 | US FAERS | |
| 239 | Blood count abnormal | FAERS: 1 | US FAERS | |
| 240 | Blood immunoglobulin G decreased | FAERS: 1 | US FAERS | |
| 241 | Blood immunoglobulin G increased | FAERS: 1 | US FAERS | |
| 242 | Blood potassium increased | FAERS: 1 | US FAERS | |
| 243 | Blood thyroid stimulating hormone decreased | FAERS: 1 | US FAERS | |
| 244 | Bone infarction | FAERS: 1 | US FAERS | |
| 245 | Bradycardia | FAERS: 1 | US FAERS | |
| 246 | Brain Contusion | FAERS: 1 | US FAERS | |
| 247 | Brain Death | FAERS: 1 | US FAERS | |
| 248 | Brain natriuretic peptide increased | FAERS: 1 | US FAERS | |
| 249 | Bronchitis | FAERS: 1 | US FAERS | |
| 250 | Cardiac infection | FAERS: 1 | US FAERS | |
| 251 | Cardiac ventricular disorder | FAERS: 1 | US FAERS | |
| 252 | Cardiac ventricular thrombosis | FAERS: 1 | US FAERS | |
| 253 | Cardiotoxicity | FAERS: 1 | US FAERS | |
| 254 | Carotid artery occlusion | FAERS: 1 | US FAERS | |
| 255 | Catarrh | FAERS: 1 | US FAERS | |
| 256 | Catheter placement | FAERS: 1 | US FAERS | |
| 257 | Cell Death | FAERS: 1 | US FAERS | |
| 258 | Central Nervous System Infection | FAERS: 1 | US FAERS | |
| 259 | Central nervous system lesion | FAERS: 1 | US FAERS | |
| 260 | Cerebral ventricle collapse | FAERS: 1 | US FAERS | |
| 261 | Cholecystitis | FAERS: 1 | US FAERS | |
| 262 | Cholestasis | FAERS: 1 | US FAERS | |
| 263 | Chronic tonsillitis | FAERS: 1 | US FAERS | |
| 264 | Clostridium difficile infection | FAERS: 1 | US FAERS | |
| 265 | Colitis | FAERS: 1 | US FAERS | |
| 266 | Concomitant disease progression | FAERS: 1 | US FAERS | |
| 267 | Congenital thrombocytopenia | FAERS: 1 | US FAERS | |
| 268 | Conjunctivitis | FAERS: 1 | US FAERS | |
| 269 | Contraindicated product administered | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 270 | Coombs test positive | FAERS: 1 | US FAERS | |
| 271 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 272 | Corynebacterium test positive | FAERS: 1 | US FAERS | |
| 273 | Creatinine renal clearance increased | FAERS: 1 | US FAERS | |
| 274 | Cyst removal | FAERS: 1 | US FAERS | |
| 275 | Cytogenetic Analysis | FAERS: 1 | US FAERS | |
| 276 | Dehydration | FAERS: 1 | US FAERS | |
| 277 | Dementia | FAERS: 1 | US FAERS | |
| 278 | Device occlusion | FAERS: 1 | US FAERS | |
| 279 | Disseminated Intravascular Coagulation | FAERS: 1 | US FAERS | |
| 280 | Drug administered to patient of inappropriate age | FAERS: 1 | US FAERS | |
| 281 | Drug administration error | FAERS: 1 | US FAERS | |
| 282 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 283 | Dysarthria | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 284 | Dysgeusia | FAERS: 1 | US FAERS | |
| 285 | Dysgraphia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 286 | Ecchymosis | FAERS: 1 | US FAERS | |
| 287 | Echography abnormal | FAERS: 1 | US FAERS | |
| 288 | Ectopic Pregnancy | FAERS: 1 | US FAERS | |
| 289 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 290 | Embolic pneumonia | FAERS: 1 | US FAERS | |
| 291 | Endocarditis | FAERS: 1 | US FAERS | |
| 292 | Erysipelas | FAERS: 1 | US FAERS | |
| 293 | Erythroblastosis | FAERS: 1 | US FAERS | |
| 294 | Evans syndrome | FAERS: 1 | US FAERS | |
| 295 | Exsanguination | FAERS: 1 | US FAERS | |
| 296 | Feeling Cold | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 297 | Fibrin D dimer increased | FAERS: 1 | US FAERS | |
| 298 | Flank Pain | FAERS: 1 | US FAERS | |
| 299 | Full blood count abnormal | FAERS: 1 | US FAERS | |
| 300 | Gastrointestinal infection | FAERS: 1 | US FAERS | |
| 301 | Gastrointestinal motility disorder | FAERS: 1 | US FAERS | |
| 302 | Gingivitis | FAERS: 1 | US FAERS | |
| 303 | Glioblastoma | FAERS: 1 | US FAERS | |
| 304 | Granulocytosis | FAERS: 1 | US FAERS | |
| 305 | Helicobacter test positive | FAERS: 1 | US FAERS | |
| 306 | Hemiparesis | FAERS: 1 | US FAERS | |
| 307 | Hepatitis B | FAERS: 1 | US FAERS | |
| 308 | Hyperchlorhydria | FAERS: 1 | US FAERS | |
| 309 | Hyperferritinaemia | FAERS: 1 | US FAERS | |
| 310 | Hypersomnia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 311 | Hypertensive crisis | FAERS: 1 | US FAERS | |
| 312 | Hypertransaminasaemia | FAERS: 1 | US FAERS | |
| 313 | Hypophagia | FAERS: 1 | US FAERS | |
| 314 | Immobile | FAERS: 1 | US FAERS | |
| 315 | Immunosuppression | FAERS: 1 | US FAERS | |
| 316 | Infarction | FAERS: 1 | US FAERS | |
| 317 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 318 | Intestinal Perforation | FAERS: 1 | US FAERS | |
| 319 | Intestinal resection | FAERS: 1 | US FAERS | |
| 320 | Iron Overload | FAERS: 1 | US FAERS | |
| 321 | Joint injury | FAERS: 1 | US FAERS | |
| 322 | Klebsiella test positive | FAERS: 1 | US FAERS | |
| 323 | Lactose Intolerance | FAERS: 1 | US FAERS | |
| 324 | Limbic Encephalitis | FAERS: 1 | US FAERS | |
| 325 | Lithiasis | FAERS: 1 | US FAERS | |
| 326 | Lupus vasculitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 327 | Lymphatic system neoplasm | FAERS: 1 | US FAERS | |
| 328 | Lymphocyte count decreased | FAERS: 1 | US FAERS | |
| 329 | Lymphocytosis | FAERS: 1 | US FAERS | |
| 330 | Lymphopenia | FAERS: 1 | US FAERS | |
| 331 | Macular degeneration | FAERS: 1 | US FAERS | |
| 332 | Marasmus | FAERS: 1 | US FAERS | |
| 333 | Mechanical ventilation | FAERS: 1 | US FAERS | |
| 334 | Meconium Aspiration Syndrome | FAERS: 1 | US FAERS | |
| 335 | Mesothelioma | FAERS: 1 | US FAERS | |
| 336 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 337 | Monocytosis | FAERS: 1 | US FAERS | |
| 338 | Multiple Sclerosis | FAERS: 1 | US FAERS | |
| 339 | Muscle Spasticity | FAERS: 1 | US FAERS | |
| 340 | Myocardial necrosis marker increased | FAERS: 1 | US FAERS | |
| 341 | Myoclonus | FAERS: 1 | US FAERS | |
| 342 | Myosclerosis | FAERS: 1 | US FAERS | |
| 343 | No adverse event | FAERS: 1 | US FAERS | |
| 344 | Nocturia | FAERS: 1 | US FAERS | |
| 345 | Nodule | FAERS: 1 | US FAERS | |
| 346 | Obesity | FAERS: 1 | US FAERS | |
| 347 | Occult blood positive | FAERS: 1 | US FAERS | |
| 348 | Ocular icterus | FAERS: 1 | US FAERS | |
| 349 | Oliguria | FAERS: 1 | US FAERS | |
| 350 | Oral mucosal exfoliation | FAERS: 1 | US FAERS | |
| 351 | Oral pain | FAERS: 1 | US FAERS | |
| 352 | Orchitis | FAERS: 1 | US FAERS | |
| 353 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 354 | Osteomyelitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 355 | Osteoporosis | FAERS: 1 | US FAERS | |
| 356 | Palpitations | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 357 | Pancreatic Cyst | FAERS: 1 | US FAERS | |
| 358 | Pancreatic Insufficiency | FAERS: 1 | US FAERS | |
| 359 | Paresis | FAERS: 1 | US FAERS | |
| 360 | Penile necrosis | FAERS: 1 | US FAERS | |
| 361 | Periodontitis | FAERS: 1 | US FAERS | |
| 362 | Peripheral embolism | FAERS: 1 | US FAERS | |
| 363 | Pneumonitis | FAERS: 1 | US FAERS | |
| 364 | Poisoning | FAERS: 1 | US FAERS | |
| 365 | Polyarthritis | FAERS: 1 | US FAERS | |
| 366 | Polyneuropathy | FAERS: 1 | US FAERS | |
| 367 | Post procedural infection | FAERS: 1 | US FAERS | |
| 368 | Posterior reversible encephalopathy syndrome | FAERS: 1 | US FAERS | |
| 369 | Priapism | FAERS: 1 | US FAERS | |
| 370 | Product administration error | FAERS: 1 | US FAERS | |
| 371 | Product use complaint | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 372 | Prostate examination abnormal | FAERS: 1 | US FAERS | |
| 373 | Protein total abnormal | FAERS: 1 | US FAERS | |
| 374 | Pulmonary arterial hypertension | FAERS: 1 | US FAERS | |
| 375 | Pulmonary sepsis | FAERS: 1 | US FAERS | |
| 376 | Pulmonary toxicity | FAERS: 1 | US FAERS | |
| 377 | Purpura | FAERS: 1 | US FAERS | |
| 378 | Red blood cell acanthocytes present | FAERS: 1 | US FAERS | |
| 379 | Red blood cell elliptocytes present | FAERS: 1 | US FAERS | |
| 380 | Renal pain | FAERS: 1 | US FAERS | |
| 381 | Reticulocyte count increased | FAERS: 1 | US FAERS | |
| 382 | Retinal Detachment | FAERS: 1 | US FAERS | |
| 383 | Retinal Vein Occlusion | FAERS: 1 | US FAERS | |
| 384 | Right ventricular failure | FAERS: 1 | US FAERS | |
| 385 | Rosacea | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 386 | Sarcoidosis | FAERS: 1 | US FAERS | |
| 387 | Senile dementia | FAERS: 1 | US FAERS | |
| 388 | Shock | FAERS: 1 | US FAERS | |
| 389 | Sinusitis | FAERS: 1 | US FAERS | |
| 390 | Skin irritation | FAERS: 1 | US FAERS | |
| 391 | Skin lesion | FAERS: 1 | US FAERS | |
| 392 | Skin necrosis | FAERS: 1 | US FAERS | |
| 393 | Sleep Talking | FAERS: 1 | US FAERS | |
| 394 | Soft tissue mass | FAERS: 1 | US FAERS | |
| 395 | Splenectomy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 396 | Splenitis | FAERS: 1 | US FAERS | |
| 397 | Stillbirth | FAERS: 1 | US FAERS | |
| 398 | Stoma complication | FAERS: 1 | US FAERS | |
| 399 | Stomatitis | FAERS: 1 | US FAERS | |
| 400 | Synovial Cyst | FAERS: 1 | US FAERS | |
| 401 | Tension | FAERS: 1 | US FAERS | |
| 402 | Therapy partial responder | FAERS: 1 | US FAERS | |
| 403 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 404 | Trisomy 21 | FAERS: 1 | US FAERS | |
| 405 | Truncus coeliacus thrombosis | FAERS: 1 | US FAERS | |
| 406 | Urinary tract obstruction | FAERS: 1 | US FAERS | |
| 407 | Vaginal lesion | FAERS: 1 | US FAERS | |
| 408 | Vascular fragility | FAERS: 1 | US FAERS | |
| 409 | Ventricular hypokinesia | FAERS: 1 | US FAERS | |
| 410 | West Nile viral infection | FAERS: 1 | US FAERS | |
| 411 | effusion | FAERS: 1 | US FAERS | |
| 412 | nervous system disorder | FAERS: 1 | US FAERS | |
| 413 | Accidental overdose | Canada Vigilance: 1 | Canada Vigilance | |
| 414 | Cyst | Canada Vigilance: 1 | Canada Vigilance | |
| 415 | Febrile Neutropenia | Canada Vigilance: 1 | Canada Vigilance | |
| 416 | Feeling jittery | Canada Vigilance: 1 | Canada Vigilance | |
| 417 | Gastric pH decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 418 | Hyperkeratosis | Canada Vigilance: 1 | Canada Vigilance | |
| 419 | Infusion site thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 420 | Product blister packaging issue | Canada Vigilance: 1 | Canada Vigilance | |
| 421 | Therapeutic product effect incomplete | Canada Vigilance: 1 | Canada Vigilance | |
| 422 | Thirst | Canada Vigilance: 1 | Canada Vigilance | |
| 423 | Vitreous floaters | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.